Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CSPC Pharmaceutical Group ( (HK:1093) ) just unveiled an update.
CSPC Pharmaceutical Group Limited announced the grant of 9,000,000 restricted shares to an employee under its share award scheme. This initiative is designed to recognize the employee’s contributions and incentivize future performance in line with the company’s strategic goals. The shares will vest in four tranches from 2026 to 2029, contingent upon the achievement of specific performance targets. This move aims to retain talent and align employee interests with the company’s growth objectives.
The most recent analyst rating on (HK:1093) stock is a Buy with a HK$12.90 price target. To see the full list of analyst forecasts on CSPC Pharmaceutical Group stock, see the HK:1093 Stock Forecast page.
More about CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a company incorporated in Hong Kong, operating in the pharmaceutical industry. It focuses on the development, manufacturing, and sale of pharmaceutical products, with a market emphasis on research and development projects aligned with strategic priorities.
Average Trading Volume: 179,196,349
Technical Sentiment Signal: Buy
Current Market Cap: HK$115.1B
For an in-depth examination of 1093 stock, go to TipRanks’ Overview page.